Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
£ 0.6
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Aptamer Group plc provides binders for research, diagnostics, and therapeutics in the United Kingdom and internationally. The company's binders engineered to address issues which founds with molecules, such as antibodies; and offers solutions to bioprocessing, diagnostic, and pharmaceutical scientists. It serves pharma companies, diagnostic development companies, and research institutes. The company was incorporated in 2014 and is based in York, the United Kingdom.
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is 'cheap' on P/E.
Data is available to registered users only
Buy
Sell